trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Glycine is generally considered an inhibitory neurotransmitter in the spinal cord, medulla and pons.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
4 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that Glycine is generally considered an inhibitory neurotransmitter in the spinal cord, medulla and pons?

Yes. Glycine functions as a well-established inhibitory neurotransmitter within the spinal cord and brainstem regions such as the medulla and pons, where it acts on strychnine-sensitive receptors to regulate motor and sensory circuits.

Verdict: SUPPORTED · 4 sources for, 0 against · Last checked

The analysis

The retrieved literature consistently supports the well-established consensus that glycine acts as an inhibitory neurotransmitter in the spinal cord and lower brainstem structures (medulla and pons), operating via specialized glycine receptors and transporters.

Evidence for · 4
GlyT1 (SLC6A9) inhibition in neurological and psychiatric disorders.
2026
Get citation
DP, C., GA, C., AÍS, N., AR, Q., LRC, N., L, C., H, U., RS, G., & MCX, P. (2026). GlyT1 (SLC6A9) inhibition in neurological and psychiatric disorders.. doi.org. https://doi.org/10.1007/s00210-026-05276-y

See more details
More for · 3
Slc6a9 is distributed in glial cells and neurons across several nervous system regions, whereas Slc6a5 is more restricted to neurons in the caudal brain.
2026
Get citation
MM, C. & MC, L. (2026). Slc6a9 is distributed in glial cells and neurons across several nervous system regions, whereas Slc6a5 is more restricted to neurons in the caudal brain.. doi.org. https://doi.org/10.1186/s12868-026-00999-3

Microbiome-derived metabolites alleviate chronic pain in a reserpine-induced model of fibromyalgia.
2026
Get citation
S, C., D, S., & WL, I. (2026). Microbiome-derived metabolites alleviate chronic pain in a reserpine-induced model of fibromyalgia.. doi.org. https://doi.org/10.1016/j.isci.2026.115406

Characterization of optogenetically activated inhibitory inputs onto cholinergic motor neurons in the spinal dorsolateral nucleus.
2025
Get citation
TC, K., S, K., K, M., S, K., M, M., SL, D., JM, B., & N, Y. (2025). Characterization of optogenetically activated inhibitory inputs onto cholinergic motor neurons in the spinal dorsolateral nucleus.. doi.org. https://doi.org/10.14814/phy2.70703

What does the evidence say?

The retrieved literature consistently supports the well-established consensus that glycine acts as an inhibitory neurotransmitter in the spinal cord and lower brainstem structures (medulla and pons), operating via specialized glycine receptors and transporters.

also asked as
  • Is glycine considered an inhibitory neurotransmitter in the spinal cord, medulla, and pons?
  • Does glycine act as an inhibitory neurotransmitter in the brainstem and spinal cord?
  • Is it true that glycine functions as an inhibitory neurotransmitter in the pons, medulla, and spinal cord?
  • Does glycine have an inhibitory role as a neurotransmitter within the spinal cord, medulla, and pons?
Receipt History
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work